Cargando…

Omics-based integrated analysis identified ATRX as a biomarker associated with glioma diagnosis and prognosis

OBJECTIVE: ATRX is a multifunctional protein that is tightly regulated by and implicated in transcriptional regulation and chromatin remodeling. Numerous studies have shown that genetic alterations in ATRX play a significant role in gliomas. This study aims to further determine the relationship betw...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xie, Yingbin, Tan, Yanli, Yang, Chao, Zhang, Xuehao, Xu, Can, Qiao, Xiaoxia, Xu, Jianglong, Tian, Shaohui, Fang, Chuan, Kang, Chunsheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Chinese Anti-Cancer Association 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6936242/ https://www.ncbi.nlm.nih.gov/pubmed/31908895 http://dx.doi.org/10.20892/j.issn.2095-3941.2019.0143

Ejemplares similares

The Role of ATRX in Glioma Biology
por: Nandakumar, Pravanya, et al.
Publicado: (2017)

Significance of TERT and ATRX mutations in glioma
por: Liu, Jiayu, et al.
Publicado: (2019)

lncRNA PRADX is a Mesenchymal Glioblastoma Biomarker for Cellular Metabolism Targeted Therapy
por: Xu, Can, et al.
Publicado: (2022)

ATRX status in patients with gliomas: Radiomics analysis
por: Meng, Linlin, et al.
Publicado: (2022)

Immunohistochemical Expression of IDH1, ATRX, Ki67, GFAP, and Prognosis in Indonesian Glioma Patients
por: Priambada, Dody, et al.
Publicado: (2023)

ATRX Loss in the Development and Prognosis of Conjunctival Melanoma
por: van Ipenburg, Jolique A., et al.
Publicado: (2023)

Clinical Neuropathology practice news 2-2014: ATRX, a new candidate biomarker in gliomas
por: Haberler, Christine, et al.
Publicado: (2014)

An immune signature to predict the prognosis of ATRX-wildtype glioma patients and guide immune checkpoint blockade therapy
por: Cao, Wenpeng, et al.
Publicado: (2023)

Targeting Telomerase and ATRX/DAXX Inducing Tumor Senescence and Apoptosis in the Malignant Glioma
por: Fan, Hueng-Chuen, et al.
Publicado: (2019)

Whole exome sequencing identifies ATRX mutation as a key molecular determinant in lower-grade glioma
por: Kannan, Kasthuri, et al.
Publicado: (2012)

ATRX regulates glial identity and the tumor microenvironment in IDH-mutant glioma
por: Babikir, Husam, et al.
Publicado: (2021)

TGFβ signaling-induced miRNA participates in autophagic regulation by targeting PRAS40 in mesenchymal subtype of glioblastoma
por: Xie, Yingbin, et al.
Publicado: (2020)

MicroRNA-1269a Promotes Proliferation and Arrest of Apoptosis of Glioma Cells by Directly Targeting ATRX
por: Zhang, Yulian, et al.
Publicado: (2020)

Capitalizing on ATRX loss in glioma via PARP inhibition: Comment on “Loss of ATRX confers DNA repair defects and PARP inhibitor sensitivity” by Garbarino et al.
por: Zalenski, Abigail A, et al.
Publicado: (2021)

ATRX immunostaining predicts IDH and H3F3A status in gliomas
por: Ebrahimi, Azadeh, et al.
Publicado: (2016)

NFB-01. FUNCTIONAL CHARACTERIZATION OF ATRX LOSS IN NF1-ASSOCIATED GLIOMA AND MPNST
por: Yuan, Ming, et al.
Publicado: (2020)

m6A modification in RNA: biogenesis, functions and roles in gliomas
por: Zhang, Yuhao, et al.
Publicado: (2020)

Disruption of ATRX-RNA interactions uncovers roles in ATRX localization and PRC2 function
por: Ren, Wenqing, et al.
Publicado: (2020)

Whole exome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomas
por: Fishbein, Lauren, et al.
Publicado: (2015)

Novel, clinically relevant genomic patterns identified by comprehensive genomic profiling in ATRX-deficient IDH-wildtype adult high-grade gliomas
por: Bedics, Gábor, et al.
Publicado: (2023)

The Multiple Facets of ATRX Protein
por: Valenzuela, Martina, et al.
Publicado: (2021)

Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas
por: Jiao, Yuchen, et al.
Publicado: (2012)

Detection of ATRX and IDH1-R132H immunohistochemistry in the progression of 211 paired gliomas
por: Cai, Jinquan, et al.
Publicado: (2016)

ATRX-Deficient High-Grade Glioma Cells Exhibit Increased Sensitivity to RTK and PDGFR Inhibitors
por: Pladevall-Morera, David, et al.
Publicado: (2022)

Multi-omics Data Integration for Identifying Osteoporosis Biomarkers and Their Biological Interaction and Causal Mechanisms
por: Qiu, Chuan, et al.
Publicado: (2020)

Integrated Multi-Omics Analysis Model to Identify Biomarkers Associated With Prognosis of Breast Cancer
por: Fan, Yeye, et al.
Publicado: (2022)

The role of PTRF/Cavin1 as a biomarker in both glioma and serum exosomes
por: Huang, Kai, et al.
Publicado: (2018)

IDH mutation, 1p19q codeletion and ATRX loss in WHO grade II gliomas
por: Leeper, Heather E., et al.
Publicado: (2015)

Atrx inactivation drives disease-defining phenotypes in glioma cells of origin through global epigenomic remodeling
por: Danussi, Carla, et al.
Publicado: (2018)

HGG-50. Specific sensitivity of pediatric high-grade glioma with ATRX inactivation to PARP inhibitor combinations
por: Laemmerer, Anna, et al.
Publicado: (2022)

The Chromatin Remodeler ATRX: Role and Mechanism in Biology and Cancer
por: Pang, Ying, et al.
Publicado: (2023)

ATRX represses alternative lengthening of telomeres
por: Napier, Christine E., et al.
Publicado: (2015)

Structural basis for DAXX interaction with ATRX
por: Wang, Xiaoman, et al.
Publicado: (2017)

Loss of ATRX and DAXX expression identifies poor prognosis for smooth muscle tumours of uncertain malignant potential and early stage uterine leiomyosarcoma
por: Slatter, Tania L., et al.
Publicado: (2015)

Identify Function of WASL in Prognosis of Cervical Cancer Based on Omics Data
por: Hou, Jinxuan, et al.
Publicado: (2021)

Inactivation of hepatic ATRX in Atrx Foxg1cre mice prevents reversal of aging-like phenotypes by thyroxine
por: Rowland, Megan E., et al.
Publicado: (2018)

MYCN amplification and ATRX mutations are incompatible in neuroblastoma
por: Zeineldin, Maged, et al.
Publicado: (2020)

The Tropomyosin Family as Novel Biomarkers in Relation to Poor Prognosis in Glioma
por: Huang, Ke, et al.
Publicado: (2022)

ATRX/EZH2 complex epigenetically regulates FADD/PARP1 axis, contributing to TMZ resistance in glioma
por: Han, Bo, et al.
Publicado: (2020)

TLR9 expression in glioma tissues correlated to glioma progression and the prognosis of GBM patients
por: Wang, Chao, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_fdp4q032qu93hrtnb3l98ffkg0